4//SEC Filing
Snyder Mark Howard 4
Accession 0001415889-25-005306
CIK 0001159036other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 5:07 PM ET
Size
8.7 KB
Accession
0001415889-25-005306
Insider Transaction Report
Form 4
Snyder Mark Howard
SVP, CHIEF LEGAL OFFICER
Transactions
- Tax Payment
Common Stock
2025-02-23$57.75/sh−3,775$218,006→ 28,489 total - Exercise/Conversion
Common Stock
2025-02-23+7,012→ 32,264 total - Exercise/Conversion
Restricted Stock Units
2025-02-23−7,012→ 21,033 totalExercise: $0.00→ Common Stock (7,012 underlying)
Footnotes (2)
- [F1]The reported disposition of 3,775 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
- [F2]This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
Documents
Issuer
HALOZYME THERAPEUTICS, INC.
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001902866
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 5:07 PM ET
- Size
- 8.7 KB